Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma

被引：0
作者：
Yi Tao
Shiwei Jin
Dan Yang
Mengmeng Pan
Wanyan Ouyang
Yuanfang Liu
Yan Wang
Weiping Zhang
Jianqing Mi
机构：
[1] National Research Center for Translational Medicine at Shanghai,Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology
[2] Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Department of Hematology
[3] Lu Daopei Hospital,undefined
来源：
BMC Cancer | / 24卷
关键词：
Multiple myeloma; Autologous stem-cell transplantation; High-risk cytogenetics; Double hit; Minimal residual disease; Real-world;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation [J].
Hovenga, S ;
de Wolf, JT ;
Guikema, JEJ ;
Klip, H ;
Smit, JW ;
Sibinga, CTS ;
Bos, NA ;
Vellenga, E .
BONE MARROW TRANSPLANTATION, 2000, 25 (07) :723-728
[42]   High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma [J].
Gertz, Marie A. ;
Lacy, Martha Q. ;
Dispenzieri, Angela ;
Hayman, Suzanne R. ;
Kumar, Shaji K. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) :343-360
[43]   Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation [J].
Chang, Hong ;
Qi, Xiaoying ;
Trieu, Young ;
Xu, Wei ;
Reader, Jocelyn C. ;
Ning, Yi ;
Reece, Donna .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (04) :486-491
[44]   Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma [J].
Yohay, Stephanie ;
Oloyede, Temitope ;
Kim, Soyoung ;
Fang, Xi ;
Dhakal, Binod ;
Aijaz, Ayesha ;
Mohan, Meera ;
Narra, Ravi ;
Pasquini, Marcelo ;
D'Souza, Anita ;
Hamadani, Mehdi ;
Freeman, Ciara Louise ;
Akhtar, Othman Salim .
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) :2370-2375
[45]   Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities [J].
Guman, Tomas ;
Sykora, Jan .
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (01) :9-11
[46]   Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups [J].
Afram, Gabriel ;
Susek, Katharina Helene ;
Uttervall, Katarina ;
Wersall, Johanna Dehlsen ;
Wagner, Arnika Kathleen ;
Luong, Vincent ;
Lund, Johan ;
Gahrton, Gosta ;
Alici, Evren ;
Nahi, Hareth .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) :546-554
[47]   Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation [J].
Peinemann, Frank ;
van Dalen, Elvira C. ;
Tushabe, Doreen A. ;
Berthold, Frank .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01)
[48]   Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [J].
Mihee Kim ;
Je-Jung Lee ;
Chang-Ki Min ;
Ji Yun Lee ;
Jae-Cheol Jo ;
Sung-Soo Yoon ;
Sung-Nam Lim ;
Young Rok Do ;
Kihyun Kim ;
Jae Hoon Lee ;
Kwai Han Yoo ;
Sung Hwa Bae ;
Jun Ho Yi ;
Jongheon Jung ;
Hyeon-Seok Eom ;
Sung-Hoon Jung .
Annals of Hematology, 2023, 102 :2233-2240
[49]   Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [J].
Kim, Mihee ;
Lee, Je-Jung ;
Min, Chang-Ki ;
Lee, Ji Yun ;
Jo, Jae-Cheol ;
Yoon, Sung-Soo ;
Lim, Sung-Nam ;
Do, Young Rok ;
Kim, Kihyun ;
Lee, Jae Hoon ;
Yoo, Kwai Han ;
Bae, Sung Hwa ;
Yi, Jun Ho ;
Jung, Jongheon ;
Eom, Hyeon-Seok ;
Jung, Sung-Hoon .
ANNALS OF HEMATOLOGY, 2023, 102 (08) :2233-2240
[50]   At least two high-risk cytogenetic abnormalities indicate the inferior outcomes for newly diagnosed multiple myeloma patients: a real-world study in China [J].
Shen, Man ;
Yang, Guangzhong ;
Li, Xin ;
Geng, Chuanying ;
Huang, Zhongxia ;
Chen, Wenming .
LEUKEMIA & LYMPHOMA, 2021, 62 (12) :2992-3001
12345